SAN FRANCISCO, CA USA (UroToday.com) - Presented by Karim Fizazi, Thomas W. Flaig, Carsten-Henning Ohlmann, Howard I. Scher, Johann Sebastian De Bono, Dana E. Rathkopf, Charles J. Ryan, Thian San Kheoh, Jinhui Li, Mary Beth Todd, Thomas W. Griffin, Arturo Molina, and Michael Stöckle at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Institut Gustave Roussy, University of Paris Sud, Villejuif, France; University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, CO; Saarland University, Homburg/Saar, Germany; Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Janssen Research & Development, LLC, Los Angeles, CA; Janssen Research & Development, LLC, Raritan, NJ; Janssen Global Services, Raritan, NJ; Janssen Research & Development, LLC, Menlo Park, CA